AINewsnow

OpenAI acquires Orchestra Bio to bring AI agents into drug development

OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,. Its staff and technology will now sit inside OpenAI's Rosalind life sciences…

Read the full story at SiliconANGLE AI ↗

Timeline · 2 reports

  1. 2026-10-21 03:32 · r/artificial
    OpenAI acquires Orchestra Bio, folds drug-development agents into Rosalind
  2. 2026-10-20 23:40 · SiliconANGLE AI
    OpenAI acquires Orchestra Bio to bring AI agents into drug development

More stories

  1. Securing our frontier model training environment — OpenAI News
  2. How Realpage. builds AI training with ChatGPT Work — OpenAI YouTube
  3. Rapidly scaling online storage to serve over 1 billion ChatGPT users (Part II) — OpenAI News
  4. AI agents for everyday IT fixes | Shield and OpenAI — OpenAI YouTube
  5. How Shield uses OpenAI’s Astra to support IT teams — OpenAI YouTube
  6. How AT&T is building AI-powered legal workflows with OpenAI — OpenAI YouTube
  7. OpenAI makes its Jev competitor widely available as decision model competition heats up — TechCrunch AI
  8. OpenClaw creator spent $10 million on AI tokens last month — InfoWorld AI

Get the daily brief of stories like this at 6:30 every morning →